HomeMedicine
Medicine
Koning Health and Gentle Scan Health Announce Partnership to Enhance Breast Cancer Detection Across the United States with 20 New Devices
NORCROSS, Ga., Dec. 18, 2023 /PRNewswire/ -- Koning Health, the leading innovator in breast CT technology, and Gentle Scan Health, LP, a venture firm dedicated to supporting better breast imaging options, are thrilled to announce their strategic partnership. This collaboration aims to revolutionize breast...
AVANTIK EXPANDS SERVICE TO DIAGNOSTIC LABORATORIES NATIONWIDE
Diagnostics Services Provider Joins Forces with CPBS Holdings & Marston Technical Services to Bolster Service Hubs, TechniciansPINE BROOK, N.J., Dec. 18, 2023 /PRNewswire/ -- Avantik announced today that it has significantly expanded its service coverage to anatomic pathology, histology, and dermatology laboratories nationwide. The company...
Europe Nucleic Acid Sample Preparation Market Analysis and Forecast to 2032 – Increasing Demand for Downstream Applications such as Next-Generation Sequencing
DUBLIN, Dec. 18, 2023 /PRNewswire/ -- The "Europe Nucleic Acid Sample Preparation Market - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.
The Europe nucleic acid sample preparation market is projected to reach $3.35 billion by 2032 from $1.30 billion in 2022, growing at a...
Ionis announces European licensing agreement with Otsuka for donidalorsen in hereditary angioedema
Otsuka to leverage strong commercial infrastructure and rare disease experience to reach European HAE patients
Ionis plans to independently bring donidalorsen to U.S. patients if approved
Donidalorsen Phase 3 results expected in the first half of 2024
CARLSBAD, Calif., Dec. 18, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc....
Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GERMANTOWN, Md., Dec. 18, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and CEO of Precigen, will present a corporate and clinical...
TransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
ANDOVER, Mass., Dec. 18, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the...